{"SPADE_UN_17662": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_UN_17662", "Peptide Name": "C16-PLL38", "Source": "Synthetic", "Family": "", "Gene": "Not found", "Sequence": "LLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLLL", "Sequence Length": 38, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Tumor cells:C26 (IC50=44µg/mL)", "Hemolytic Activity": "Not available", "Cytotoxicity": "HUVEC:IC50=126µg/mL", "Binding Target": "Not available", "Linear/Cyclic": "Linear", "N-terminal Modification": "C16", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C228H420N38O39", "Mass": 4318.0, "PI": 5.53, "Net Charge": 0, "Hydrophobicity": 3.8, "Half Life": "Mammalian:5.5 hourYeast:3 minE.coli:2 min", "Literature": [{"Title": "Synthetic lipo-polylysine with anti-cancer activity", "Pubmed ID": "37605903", "Reference": "2023 Sep 26;11(19)6611-6626", "Author": "Yi X, Wan P, Shen W, Zhang X, Zhang P, Xiao C.", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=37605903"}], "Frequent Amino Acids": "L", "Absent Amino Acids": "ACDEFGHIKMNOPQRSTUVWY", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 38, "Polar Residues": 0, "Positive Residues": 0, "Negative Residues": 0, "Similar Sequences": [{"SPADE_ID": "SPADE_N_05522", "Similarity": 1.0, "Sequence": "LLLE"}, {"SPADE_ID": "SPADE_N_07291", "Similarity": 1.0, "Sequence": "LLLR"}, {"SPADE_ID": "SPADE_N_07292", "Similarity": 1.0, "Sequence": "LLLLR"}]}}}